Literature DB >> 12361187

Change in blood pressure in the age interval 70-90. Late blood pressure peak related to longer survival.

Bodil Lernfelt1, Alvar Svanborg.   

Abstract

AIMS: To investigate longitudinal changes in systolic (SBP) and diastolic blood pressure (DBP) between age 70 and 90, and to analyse the relationship between blood pressure changes after 70 and survival in two representative population samples (n = 973 and n = 1036). MAJOR
FINDINGS: In the total population sample, SBP increased up to age 75 and declined thereafter. In survivors up to 90, SBP increased up to age 79 and decreased thereafter. DBP decreased after 70. Up to age 82, women had higher SBP and DBP than men. Low SBP at 70 and 75 were correlated to longer survival in both sexes. The relation between blood pressure peak and survival up to age 90 was analysed in 424 men and 640 women, all examined at 70, 75 and 79 years. Twenty-six per cent of men and 44% of women with the highest SBP at 79 survived up to 90 years compared with 15% of men and 31% of women with the highest SBP at 70. SBP and DBP at age 90 were higher in survivors up to age 93 compared with non-survivors. PRINCIPAL
CONCLUSION: Low blood pressure at 70 and late SBP peak were related to longer survival after age 79.

Entities:  

Mesh:

Year:  2002        PMID: 12361187     DOI: 10.1080/08037050213759

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  8 in total

1.  NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study.

Authors:  Peter van Vliet; Behnam Sabayan; Liselotte W Wijsman; Rosalinde K E Poortvliet; Simon P Mooijaart; Wouter de Ruijter; Jacobijn Gussekloo; Anton J M de Craen; R G J Westendorp
Journal:  Neurology       Date:  2014-08-20       Impact factor: 9.910

2.  Changing prediction of mortality by systolic blood pressure with increasing age: the Rotterdam study.

Authors:  J W Blom; W de Ruijter; J C M Witteman; W J J Assendelft; M M B Breteler; A Hofman; J Gussekloo
Journal:  Age (Dordr)       Date:  2011-12-15

3.  Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk.

Authors:  Yvonne M Drewes; Rosalinde K E Poortvliet; Jeanet W Blom; Wouter de Ruijter; Rudi G J Westendorp; David J Stott; Henk J Blom; Ian Ford; Naveed Sattar; J Wouter Jukema; Willem J J Assendelft; Anton J M de Craen; Jacobijn Gussekloo
Journal:  J Am Geriatr Soc       Date:  2014-01-21       Impact factor: 5.562

4.  Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study.

Authors:  Bert Vaes; Paulien Indestege; Tinne Serneels; Eralda Hegendörfer; Petra G van Peet; Rosalinde K E Poortvliet; Pierre Wallemacq; Jacobijn Gussekloo; Jan Degryse
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

Review 5.  Prevention of cardiovascular events by treating hypertension in older adults: an evidence-based approach.

Authors:  Muhammad Firdaus; Chittur A Sivaram; Dwight W Reynolds
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

6.  Blood Pressure and All-Cause Mortality by Level of Cognitive Function in the Elderly: Results From a Population-Based Study in Rural Greece.

Authors:  Marios K Georgakis; Athanasios D Protogerou; Eleni I Kalogirou; Evangelia Kontogeorgi; Ioanna Pagonari; Fani Sarigianni; Sokratis G Papageorgiou; Elisabeth Kapaki; Charalampos Papageorgiou; Dimitrios Tousoulis; Eleni Th Petridou
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-19       Impact factor: 3.738

7.  The association between SBP and mortality risk differs with level of cognitive function in very old individuals.

Authors:  Bodil Weidung; Håkan Littbrand; Peter Nordström; Bo Carlberg; Yngve Gustafson
Journal:  J Hypertens       Date:  2016-04       Impact factor: 4.844

8.  Systolic blood pressure decline in very old individuals is explained by deteriorating health: Longitudinal changes from Umeå85+/GERDA.

Authors:  Bodil Weidung; Annika Toots; Peter Nordström; Bo Carlberg; Yngve Gustafson
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.